Ftse Mib
33.746,66
-1,60%
DAX
17.932,17
-1,10%
S&P 500
5.035,69
-1,57%
NASDAQ Composite
15.657,82
-2,04%
Bitcoin
60.421,87
-5,35%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Exscientia PLC (EXAI) Exscientia PLC (EXAI) Notizie

Exscientia PLC

EXAI
5,17
0,55 (11,90%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 00:51:22
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
21/3/202412:26IHMARKETNEWSU.S. Index Futures Rise as Fed’s Dovish Outlook Spurs..
21/3/202412:00BWExscientia Business and Financial Update for the Full Year..
14/3/202416:29BWExscientia berichtet am 21. März 2024 über die..
14/3/202412:00BWExscientia to Report Full Year 2023 Financial Results on..
29/2/202414:20BWExscientia präsentiert auf kommenden Investorenkonferenzen..
28/2/202415:08BWExscientia participera à de prochaines conférences..
28/2/202413:00BWExscientia to Present at Upcoming Investor Conferences in..
13/2/202412:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/2/202417:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202419:45BWExscientia lance une étude clinique pour approfondir..
07/2/202413:00BWExscientia Initiates Clinical Study to Further Evaluate..
08/1/202422:10EDGAR2Form 144 - Report of proposed sale of securities
02/1/202416:36BWLe professeur Andrew L. Hopkins est nommé Commandeur de..
02/1/202416:28BWProfessor Andrew L. Hopkins zum Commander of the Order of..
02/1/202413:00BWProfessor Andrew L. Hopkins appointed Commander of the Order..
21/12/202319:09BWExscientia annonce une extension de sa collaboration..
21/12/202315:45BWExscientia gibt die Ausweitung der aktuellen Zusammenarbeit..
21/12/202313:00BWExscientia Announces Expansion of its Current Collaboration..
05/12/202319:54BWExscientia reçoit une subvention d’Open Philanthropy pour..
05/12/202318:11BWExscientia erhält Zuschüsse von Open Philanthropy zur..
05/12/202313:00BWExscientia Receives Open Philanthropy Grant to Explore New..
21/11/202320:26BWExscientia präsentiert sich auf der 6. Jahreskonferenz..
21/11/202317:52BWExscientia participera à la 6e conférence annuelle Evercore..
21/11/202313:00BWExscientia to Present at the 6th Annual Evercore ISI..
09/11/202313:58EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/11/202313:00BWExscientia Business Update for Third Quarter 2023
02/11/202317:36BWExscientia publiera ses résultats financiers du troisième..
02/11/202312:00BWExscientia to Report Third Quarter 2023 Financial Results on..
17/10/202318:01BWParker Moss rejoint Exscientia au poste de VP exécutif,..
17/10/202318:00BWParker Moss kommt als EVP, Corporate Development, zu..
17/10/202313:00BWParker Moss to Join Exscientia as EVP, Corporate Development
16/10/202320:10BWExscientia präsentiert auf dem ESMO 2023 neue präklinische..
16/10/202313:00BWExscientia to Present New Preclinical Data for AI-designed..
03/10/202322:37BWExscientia detailliert Strategie zur Pipeline-Priorisierung
03/10/202321:12BWExscientia explique sa stratégie de hiérarchisation des..
03/10/202314:00BWExscientia Details Pipeline Prioritisation Strategy
20/9/202322:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/9/202314:43BWExscientia beginnt KI-Zusammenarbeit im Bereich Drug..
20/9/202312:47DJNExscientia Shares Rally Premarket on Lucrative Merck Deal
20/9/202312:13BWExscientia annonce une collaboration avec Merck KGaA,..
20/9/202307:00BWExscientia Announces AI Drug Discovery Collaboration with..
31/8/202318:23BWExscientia hält Vortrag bei Investorenkonferenzen im..
31/8/202315:37BWExscientia effectuera des présentations à l’occasion de..
31/8/202313:00BWExscientia to Present at Upcoming Investor Conferences in..
10/8/202313:38EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/8/202313:00BWExscientia Business Update for Second Quarter and First Half..
03/8/202313:00BWExscientia to Report Second Quarter 2023 Financial Results..
19/7/202302:29BWエクセンシア、卵巣がんのプロスペクティブ観察研究を開始
18/7/202321:15BWExscientia startet prospektive Beobachtungsstudie zu..
18/7/202319:15BWExscientia lance une étude observationnelle prospective sur..
Apertura: 4,68 Min: 4,62 Max: 5,18
Chiusura: 4,62

La tua Cronologia

NASDAQ
EXAI
Exscientia
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network